TET2 Downregulation Leads to AML Cells Sensitive to Decitabine

被引:0
|
作者
Chen, Qingxiao [1 ]
He, Jingsong [1 ]
Guo, Xing [1 ]
Chen, Jing [1 ]
Yang, Li [1 ]
Lin, Xuanru [1 ]
Li, Yi [1 ]
Zhang, Enfan [1 ]
Yang, Yang [1 ]
Wu, Wenjun [1 ]
He, Donghua [1 ]
Huang, He [1 ]
Liu, Shizhou [2 ]
Cai, Zhen [1 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Inst Translat Med, Hangzhou 310003, Zhejiang, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] TET2 Downregulation Promotes AML Cell Proliferation Via Pim-1 Expression
    Chen, Qingxiao
    He, Jingsong
    Guo, Xing
    Chen, Jing
    Lin, Xuanru
    Huang, Xi
    Yan, Haimeng
    Yang, Li
    Li, Yi
    Zhang, Enfan
    Yang, Yang
    Huang, He
    Cai, Zhen
    BLOOD, 2016, 128 (22)
  • [2] Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells
    Pan, Feng
    Wingo, Thomas S.
    Zhao, Zhigang
    Gao, Rui
    Makishima, Hideki
    Qu, Guangbo
    Lin, Li
    Yu, Miao
    Ortega, Janice R.
    Wang, Jiapeng
    Nazha, Aziz
    Chen, Li
    Yao, Bing
    Liu, Can
    Chen, Shi
    Weeks, Ophelia
    Ni, Hongyu
    Phillips, Brittany Lynn
    Huang, Suming
    Wang, Jianlong
    He, Chuan
    Li, Guo-Min
    Radivoyevitch, Tomas
    Aifantis, Iannis
    Maciejewski, Jaroslaw P.
    Yang, Feng-Chun
    Jin, Peng
    Xu, Mingjiang
    NATURE COMMUNICATIONS, 2017, 8
  • [3] Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells
    Feng Pan
    Thomas S. Wingo
    Zhigang Zhao
    Rui Gao
    Hideki Makishima
    Guangbo Qu
    Li Lin
    Miao Yu
    Janice R. Ortega
    Jiapeng Wang
    Aziz Nazha
    Li Chen
    Bing Yao
    Can Liu
    Shi Chen
    Ophelia Weeks
    Hongyu Ni
    Brittany Lynn Phillips
    Suming Huang
    Jianlong Wang
    Chuan He
    Guo-Min Li
    Tomas Radivoyevitch
    Iannis Aifantis
    Jaroslaw P. Maciejewski
    Feng-Chun Yang
    Peng Jin
    Mingjiang Xu
    Nature Communications, 8
  • [4] Diverse Landscape of TET2 Variants in MDS and AML
    Tallis, Eran
    Benton, Christopher B.
    Khan, Abir
    Assi, Rita
    DiNardo, Courtney D.
    Hornbaker, Marisa J.
    Major, Catherine Kendall
    Boddu, Prajwal
    Kanagal-Shamanna, Rashmi
    Patel, Keyur P.
    Daver, Naval G.
    Takahashi, Koichi
    Montalban-Bravo, Guillermo
    Kadia, Tapan M.
    Konopleva, Marina Y.
    Andreeff, Michael
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    BLOOD, 2018, 132
  • [5] TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML) TET2 exon 2 skipping in AML
    Mohamed, Aminetou Mint
    Balsat, Marie
    Koering, Catherine
    Maucort-Boulch, Delphine
    Boissel, Nicolas
    Payen-Gay, Lea
    Cheok, Meyling
    Mortada, Hussein
    Auboeuf, Didier
    Pinatel, Christiane
    El-Hamri, Mohamed
    Tigaud, Isabelle
    Hayette, Sandrine
    Dumontet, Charles
    Cros, Emeline
    Flandrin-Gresta, Pascale
    Nibourel, Olivier
    Preudhomme, Claude
    Thomas, Xavier
    Nicolini, Franck-Emmanuel
    Solly, Francoise
    Guyotat, Denis
    Campos, Lydia
    Michallet, Mauricette
    Ceraulo, Antony
    Mortreux, Franck
    Wattel, Eric
    LEUKEMIA RESEARCH, 2017, 56 : 21 - 28
  • [6] Lower Levels of TET2 Gene Expression, with a Higher Level of TET2 Promoter Methylation in Patients with AML; Evidence for the Role of Aberrant Methylation in AML Pathogenesis
    Ghasemi, Bahare
    Ahmadi, Javad
    Zaker, Farhad
    Tabatabaei, Tahere
    Kiani-Zadeh, Masoumeh
    Kazemi, Ahmad
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (01) : 52 - 60
  • [7] Lower Levels of TET2 Gene Expression, with a Higher Level of TET2 Promoter Methylation in Patients with AML; Evidence for the Role of Aberrant Methylation in AML Pathogenesis
    Bahare Ghasemi
    Javad Ahmadi
    Farhad Zaker
    Tahere Tabatabaei
    Masoumeh Kiani-Zadeh
    Ahmad Kazemi
    Indian Journal of Hematology and Blood Transfusion, 2024, 40 : 52 - 60
  • [8] Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis
    Rasmussen, Kasper D.
    Jia, Guangshuai
    Johansen, Jens V.
    Pedersen, Marianne T.
    Rapin, Nicolas
    Bagger, Frederik O.
    Porse, Bo T.
    Bernard, Olivier A.
    Christensen, Jesper
    Helin, Kristian
    GENES & DEVELOPMENT, 2015, 29 (09) : 910 - 922
  • [9] Epigenetic Profiling Of Leukemia Stem Cells In a Model Of TET2/FLT3-Mutant AML
    Shih, Alan H.
    Jiang, Yanwen
    Shank, Kaitlyn
    Pandey, Suveg
    Viale, Agnes
    Sun, Yongming
    Socci, Nicholas
    Robertson, Alexander
    de Stanchina, Elisa
    Hricik, Todd
    Rapaport, Franck
    Woods, Brittany
    Cimmino, Luisa
    Barreyro, Laura
    Steidl, Ulrich
    Aifantis, Iannis
    Melnick, An
    Levine, Ross L.
    BLOOD, 2013, 122 (21)
  • [10] Tet2 Deficiency Leads to an Increased Inflammatory Phenotype in Murine Macrophages
    Cull, Alyssa
    Snetsinger, Brooke
    Rauh, Michael J.
    BLOOD, 2016, 128 (22)